These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28630393)

  • 1. Sample size re-estimation without un-blinding for time-to-event outcomes in oncology clinical trials.
    Huang LH; Bai JL; Yu H; Chen F
    J Biomed Res; 2017 Jun; 32(1):23-9. PubMed ID: 28630393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow up after sample size re-estimation in a breast cancer randomized trial for disease-free survival.
    Hade EM; Young GS; Love RR
    Trials; 2019 Aug; 20(1):527. PubMed ID: 31443726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blinded assessment of treatment effects for survival endpoint in an ongoing trial.
    Xie J; Quan H; Zhang J
    Pharm Stat; 2012; 11(3):204-13. PubMed ID: 22337644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size re-estimation in a breast cancer trial.
    Hade EM; Jarjoura D; Lai Wei
    Clin Trials; 2010 Jun; 7(3):219-26. PubMed ID: 20392786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robustness of methods for blinded sample size re-estimation with overdispersed count data.
    Schneider S; Schmidli H; Friede T
    Stat Med; 2013 Sep; 32(21):3623-35. PubMed ID: 23595966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the inappropriateness of an EM algorithm based procedure for blinded sample size re-estimation.
    Friede T; Kieser M
    Stat Med; 2002 Jan; 21(2):165-76. PubMed ID: 11782057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regularized EM algorithm for sparse parameter estimation in nonlinear dynamic systems with application to gene regulatory network inference.
    Jia B; Wang X
    EURASIP J Bioinform Syst Biol; 2014; 2014(1):5. PubMed ID: 24708632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of the expectation-maximization (EM) algorithm for maximum likelihood estimation of gametic frequencies of multilocus polymorphic codominant systems based on sampled population data].
    Sergeev AS; Arapova RK
    Genetika; 2002 Mar; 38(3):407-18. PubMed ID: 11963570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Employing a Monte Carlo algorithm in expectation maximization restricted maximum likelihood estimation of the linear mixed model.
    Matilainen K; Mäntysaari EA; Lidauer MH; Strandén I; Thompson R
    J Anim Breed Genet; 2012 Dec; 129(6):457-68. PubMed ID: 23148971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A post hoc evaluation of a sample size re-estimation in the Secondary Prevention of Small Subcortical Strokes study.
    McClure LA; Szychowski JM; Benavente O; Hart RG; Coffey CS
    Clin Trials; 2016 Oct; 13(5):537-44. PubMed ID: 27094488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical Inference of the Generalized Inverted Exponential Distribution under Joint Progressively Type-II Censoring.
    Chen Q; Gui W
    Entropy (Basel); 2022 Apr; 24(5):. PubMed ID: 35626461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximum likelihood inference for multivariate frailty models using an automated Monte Carlo EM algorithm.
    Ripatti S; Larsen K; Palmgren J
    Lifetime Data Anal; 2002 Dec; 8(4):349-60. PubMed ID: 12471944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size re-estimation for survival data in clinical trials with an adaptive design.
    Togo K; Iwasaki M
    Pharm Stat; 2011; 10(4):325-31. PubMed ID: 22328325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attraction-repulsion expectation-maximization algorithm for image reconstruction and sensor field estimation.
    Hong H; Schonfeld D
    IEEE Trans Image Process; 2009 Sep; 18(9):2004-11. PubMed ID: 19502130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution Theory Following Blinded and Unblinded Sample Size Re-estimation under Parametric Models.
    Tarima S; Flournoy N
    Commun Stat Simul Comput; 2022; 51(4):2053-2064. PubMed ID: 35755487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blinded sample size re-estimation in crossover bioequivalence trials.
    Golkowski D; Friede T; Kieser M
    Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
    Friede T; Kieser M
    Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the Expectation-Maximization Algorithm for Rice-Rayleigh Mixtures With Application to Noise Parameter Estimation in Magnitude MR Datasets.
    Maitra R
    Sankhya B (2008); 2013 Nov; 75(2):293-318. PubMed ID: 29757335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.